BERKELEY HEIGHTS, N.J., May 6, 2014 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (Nasdaq:CYCC) (Nasdaq:CYCCP) (“Cyclacel” or the “Company”), a biopharmaceutical company developing oral therapies that target the various phases of cell cycle control for the treatment of cancer and other serious disorders, will announce financial results for the first quarter ended March 31, 2014 on Tuesday, May 13, 2014. The Company will host a conference call and live webcast at 4:30 pm Eastern time on the same day.
Help employers find you! Check out all the jobs and post your resume.
